- Home
- ONCO vs LGHL Comparison
ONCO vs LGHL Comparison
Compare ONCO & LGHL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ONCO
- LGHL
- Stock Information
- Founded
- ONCO 2018
- LGHL 2015
- Country
- ONCO United States
- LGHL Singapore
- Employees
- ONCO N/A
- LGHL N/A
- Industry
- ONCO Biotechnology: Pharmaceutical Preparations
- LGHL Investment Bankers/Brokers/Service
- Sector
- ONCO Health Care
- LGHL Finance
- Exchange
- ONCO Nasdaq
- LGHL Nasdaq
- Market Cap
- ONCO 1.8M
- LGHL 1.5M
- IPO Year
- ONCO 2022
- LGHL N/A
- Fundamental
- Price
- ONCO $4.31
- LGHL $2.90
- Analyst Decision
- ONCO
- LGHL
- Analyst Count
- ONCO 0
- LGHL 0
- Target Price
- ONCO N/A
- LGHL N/A
- AVG Volume (30 Days)
- ONCO 241.4K
- LGHL 2.1M
- Earning Date
- ONCO 08-28-2025
- LGHL 07-15-2025
- Dividend Yield
- ONCO N/A
- LGHL N/A
- EPS Growth
- ONCO N/A
- LGHL N/A
- EPS
- ONCO N/A
- LGHL N/A
- Revenue
- ONCO $1,925,313.00
- LGHL N/A
- Revenue This Year
- ONCO N/A
- LGHL N/A
- Revenue Next Year
- ONCO N/A
- LGHL N/A
- P/E Ratio
- ONCO N/A
- LGHL N/A
- Revenue Growth
- ONCO 153.70
- LGHL N/A
- 52 Week Low
- ONCO $3.82
- LGHL $2.13
- 52 Week High
- ONCO $1,190.00
- LGHL $21.15
- Technical
- Relative Strength Index (RSI)
- ONCO 38.91
- LGHL 49.39
- Support Level
- ONCO $4.40
- LGHL $2.53
- Resistance Level
- ONCO $5.09
- LGHL $3.27
- Average True Range (ATR)
- ONCO 0.47
- LGHL 0.55
- MACD
- ONCO 0.07
- LGHL 0.02
- Stochastic Oscillator
- ONCO 38.28
- LGHL 19.93
About ONCO Onconetix Inc.
Onconetix Inc is a commercial-stage biotechnology company focused on the research, development, and commercialization of innovative solutions for men's health and oncology. It has a product named Entadfi an FDA-approved once-daily oral therapeutic for the treatment of benign prostatic hyperplasia, a disorder of the prostate, along with building additional assets in therapeutics, diagnostics, and clinician services for oncology.
About LGHL Lion Group Holding Ltd.
Lion Group Holding Ltd is an investor-focused trading platform that offers various products and services. The company's current business lines include total return swap (TRS) trading business, contracts for difference (CFD) trading services, Hong Kong-based Over-The-Counter (OTC) stock options trading business, and futures and securities brokerage services. It provides these services through its Lion Brokers Pro and a variety of other applications. The company generates a majority of its revenue from its CFD trading services business. Geographically, the firm's key revenue-generating market is Hong Kong.